| 2024 | Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicenter observational study
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2024 | PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer | NPJ PRECISION ONCOLOGY |
| 2024 | Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study
| GUT AND LIVER |
| 2024 | Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer
| BMC CANCER |
| 2024 | Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer
| SCIENTIFIC REPORTS |
| 2024 | Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis
| GENOME MEDICINE |
| 2024 | Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction
| AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2024 | Comparison of Physician-Controlled Maneuver and Assistant-Controlled Maneuver during Endoscopic Retrograde Cholangiopancreatography
| YONSEI MEDICAL JOURNAL |
| 2024 | Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive Diagnosis of Pancreatic Solid Lesions
| GUT AND LIVER |
| 2023 | Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study
| FRONTIERS IN ONCOLOGY |
| 2023 | Adjuvant Chemotherapy and Effect on Long-Term Survival in Ampullary Adenocarcinoma: A Multicenter Cohort Study | JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS |
| 2023 | A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer | GASTROENTEROLOGY |
| 2023 | Long-term outcomes of endoscopic papillectomy for ampullary adenoma with high-grade dysplasia or adenocarcinoma: a propensity score-matched analysis | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
| 2023 | Impact of cholecystectomy on acute coronary syndrome according to metabolic condition: a nationwide population-based cohort study
| SCIENTIFIC REPORTS |
| 2023 | Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM |
| 2023 | Response | GASTROINTESTINAL ENDOSCOPY |
| 2023 | Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer | CANCER RESEARCH |
| 2023 | The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer
| GUT AND LIVER |
| 2023 | Plasmon-Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis
| ADVANCED SCIENCE |
| 2023 | Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial | GASTROINTESTINAL ENDOSCOPY |
| 2023 | Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
| NATURE COMMUNICATIONS |
| 2023 | Machine-Learning Model for the Prediction of Hypoxaemia during Endoscopic Retrograde Cholangiopancreatography under Monitored Anaesthesia Care
| YONSEI MEDICAL JOURNAL |
| 2022 | A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
| INTERNATIONAL JOURNAL OF CANCER |
| 2022 | Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
| SCIENTIFIC REPORTS |
| 2022 | Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer
| CANCERS |
| 2022 | Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer
| CANCERS |
| 2022 | Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial
| CANCERS |
| 2022 | Healthcare vulnerability disparities in pancreatic cancer treatment and mortality using the Korean National Sample Cohort: a retrospective cohort study
| BMC CANCER |
| 2022 | 담관암의 선행 항암 치료와 수술 후 보조 항암 치료
| Korean Journal of Pancreas and Biliary Tract(대한췌담도학회지) |
| 2022 | Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9 | RADIOLOGY |
| 2022 | Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study
| CANCERS |
| 2022 | Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis
| GUT AND LIVER |
| 2022 | BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients
| CANCERS |
| 2021 | Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2021 | GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma
| BMC CANCER |
| 2021 | Optimal drainage of anastomosis stricture after living donor liver transplantation | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
| 2021 | Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches | PANCREATOLOGY |
| 2021 | Usefulness of Smartphone Apps for Improving Nutritional Status of Pancreatic Cancer Patients: Randomized Controlled Trial
| JMIR MHEALTH AND UHEALTH |
| 2021 | Long-term outcomes of fully covered self-expandable metal stents versus plastic stents in chronic pancreatitis
| SCIENTIFIC REPORTS |
| 2021 | Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
| CANCERS |
| 2021 | Comparison of high flow nasal oxygen and conventional nasal cannula during gastrointestinal endoscopic sedation in the prone position: a randomized trial | CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE |
| 2021 | Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer | EBIOMEDICINE |
| 2021 | Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy | ABDOMINAL RADIOLOGY |
| 2021 | Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population | ACTA RADIOLOGICA |
| 2021 | Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized Algorithm
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2021 | COVID-19 기간 대한췌장담도학회의 대면-비대면 학술행사에 대한 만족도 설문 조사
| Korean Journal of Pancreas and Biliary Tract (대한췌담도학회지) |
| 2021 | Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study | PANCREATOLOGY |
| 2021 | Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
| 2020 | Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging? | PANCREATOLOGY |
http://orcid.org/0000-0002-2825-3160
(56713997700)
